Log in  First Connection?

Interventional CardiologyArchives

Long-term successfully endovascular treatment of a complicated Takayasu’s arteritis with thrombectomy and stenting: a case report

 Published on 05/05/2025 |  Original article (Full-text)  | Chirico Claudio et al. | Journal of Medical Case Reports 2024; 19(1): 202

Takayasu arteritis (TAK) is a large‐vessel vasculitis (LVV) of unknown etiology, characterized by granulomatous inflammation that primarily affects the aorta and its major branches, particularly the subclavian, common carotid, and internal carotid arteries [1, 2]. Its incidence is variable, ranging...

Comparison of complete vs. culprit-only revascularization in acute myocardial infarction

 Published on 28/04/2025 |  Original article (Full-text)  | Chen Ran et al. | BMC Cardiovascular Disorders 2025; 25(1): 325

Acute myocardial infarction (AMI), a major disease threatening human health and causing death, is characterized by acute coronary occlusion and myocardial ischemic necrosis, with a high risk of death. Emergency percutaneous coronary intervention (PCI) should be performed as soon as possible to open the...

Effect of enhanced external counterpulsation on the rehabilitation of patients with acute myocardial infarction after drug-coated balloon-based percutaneous coronary intervention

 Published on 21/04/2025 |  Original article (Full-text)  | Hao Xiaojiao et al. | Journal of Cardiothoracic Surgery 2024; 20(1): 210

Cardiovascular diseases are responsible for increased morbidity and mortality in China’s population; this may be a result of an ageing population and the prevalence of metabolic risk factors [1]. Cardiovascular diseases are responsible for 40% of deaths, particularly premature death, in China [1,...

Prediction of myocardial ischemia–reperfusion injury post-PCI: role of sST2 levels in STEMI patients

 Published on 14/04/2025 |  Original article (Full-text)  | Che Wenjing et al. | BMC Cardiovascular Disorders 2025; 25(1): 280

ST-segment elevation myocardial infarction (STEMI) is associated with high levels of morbidity and mortality, along with a difficult prognosis. The mortality rate in hospitals for patients experiencing STEMI is around 4–21% [1]. The most effective method for reducing myocardial necrosis in the...